Home › Funds › Novo Holdings A/S › MPLT
Novo Holdings A/S position in MPLT
MAPLIGHT THERAPEUTICS INC · Health Care
Novo Holdings A/S reported holding 2,086,622 shares of MPLT (MAPLIGHT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$21.3M, representing 1.43% of its reported portfolio and ranking #21 among its reported holdings. Novo Holdings A/S has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Novo Holdings A/S's MPLT position evolved
Novo Holdings A/S first disclosed a stake in MPLT in Q4 2025 at 3,686,622 shares (US$64.8M). The position peaked in Q2 2026 at 3,686,622 shares, worth US$132.1M. Across 4 filings, Novo Holdings A/S increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,086,622 shares valued at US$21.3M — a reduction of -1,600,000 shares quarter over quarter.. Notable position changes include a 43% trim in Q3 2026 (shares fell 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 3.69M | $64.76M | New |
| Q1 2026 | 3.69M | $74.95M | Hold |
| Q2 2026 | 3.69M | $132.13M | Hold |
| Q3 2026 | 2.09M | $21.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MPLT and 13F data
MPLT (MAPLIGHT THERAPEUTICS INC) is a Health Care company. 81 other funds we track also report a position in MPLT — the largest reported positions include FCPM III SERVICES B.V. (US$45.1M), Nan Fung Group Holdings Ltd (US$23.4M), Sanofi (US$9.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MPLT
- FCPM III SERVICES B.V. 4.43M sh · $45.12M · Q3 2026
- Nan Fung Group Holdings Ltd 2.30M sh · $23.44M · Q3 2026
- Sanofi 912.04K sh · $9.29M · Q3 2026
- 5AM Venture Management, LLC 741.89K sh · $7.56M · Q3 2026
- Velan Capital Investment Management LP 624.70K sh · $6.37M · Q3 2026
- Pivotal bioVenture Partners Investment Advisor LLC 611.45K sh · $6.23M · Q3 2026
- Blue Owl Capital Holdings LP 556.37K sh · $5.67M · Q3 2026
- DAFNA Capital Management LLC 155.58K sh · $1.59M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 118.30K sh · $1.21M · Q3 2026
More on Novo Holdings A/S
FAQ
How long has Novo Holdings A/S held MPLT?
Novo Holdings A/S has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Novo Holdings A/S's current position in MPLT?
As of Q3 2026, Novo Holdings A/S holds 2.09M shares of MPLT (MAPLIGHT THERAPEUTICS INC), valued at $21.26M, representing 1.43% of its reported portfolio and ranking #21.
Has Novo Holdings A/S been buying or selling MPLT?
In the latest 13F filing (Q3 2026), Novo Holdings A/S reduced its position in MPLT. The position peaked in Q2 2026 at 3.69M shares.
Which other funds hold MPLT?
Other major institutional holders of MPLT include FCPM III SERVICES B.V., Nan Fung Group Holdings Ltd, Sanofi, among 81 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.